C World Wide Group Holding A Amarin Corp Plcuk Transaction History

C World Wide Group Holding A

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$4.04 - $5.31 $3.68 Million - $4.84 Million	-911,329 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$4.78 - $8.26 $956,000 - $1.65 Million	200,000 Added 28.12%	911,329 $6.31 Million
Q1 2020 May 04, 2020	BUY	$4.0 - $21.53 $400,000 - $2.15 Million	100,000 Added 16.36%	711,329 $2.85 Million
Q4 2019 Feb 05, 2020	SELL	$13.94 - $24.12 $2.09 Million - $3.62 Million	-150,000 Reduced 19.7%	611,329 $13.1 Million
Q1 2019 May 03, 2019	BUY	$12.61 - $22.33 $1.62 Million - $2.87 Million	128,463 Added 20.3%	761,329 $15.8 Million
Q4 2018 Feb 12, 2019	SELL	$12.41 - $22.98 $584,932 - $1.08 Million	-47,134 Reduced 6.93%	632,866 $8.61 Million
Q3 2018 Nov 05, 2018	BUY	$2.45 - $16.27 $1.67 Million - $11.1 Million	680,000 New	680,000 $11.1 Million

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.